Jinshi Asia Pharmaceutical announced that Jinshi Technology, a wholly-owned first-level subsidiary of the company, signed the “Mask Edition High-Performance Coating Equipment R&D Project “Two-way Unveiling and Leading Project Status Agreement”. The total investment of the project is 30 million yuan. Jinshi Technology is estimated to bear the equipment manufacturing R&D expenses of no less than 18 million yuan. The project implementation period is from March 2026 to June 2027.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.